Curative Biotechnology Inc (CUBT:OTCMKTS)

$0.0064 -0.00 (-13.51%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 71

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed Curative Biotechnology Inc (CUBT:OTCMKTS) News Sources

Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board

Yahoo Finance

external link

Astellas and Vir Biotechnology collaborate to advance PSMA-targeting PRO-XTEN dual-masked T-cell engager VIR-5500 to treat prostate cancer

Pharmabiz

external link

Fortress Biotech, Inc.: Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million

FinanzNachrichten.de

external link

Astellas Pharma Inc.: Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN Dual-masked T-Cell Engager VIR-5500 for the ...

FinanzNachrichten.de

external link

Vir Biotechnology, Inc. (VIR) Q4 2025 Earnings Call Transcript

Seeking Alpha

external link

Which Is a Better Investment, Arrowhead Pharmaceuticals, Inc. or Celldex Therapeutics, Inc. Stock?

American Association of Individual Investors

external link

Fortress Biotech’s Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million

The Manila Times

external link

MAIA Biotechnology’s Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market

Yahoo Finance

external link

CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors

Yahoo Finance UK

external link

Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer

Le Lézard

external link
CUBT stock
CUBT stock price
CUBT stock price today
CUBT stock prediction
CUBT earnings date
CUBT news
CUBT price
CUBT share
CUBT share price
CUBT shares
CUBT ceo
CUBT premarket
$CUBT
CUBT ticker
CUBT after hours
CUBT stock
CUBT stock price
CUBT stock price today
CUBT stock prediction
CUBT earnings date
CUBT news
CUBT price
CUBT share
CUBT share price
CUBT shares
CUBT ceo
CUBT premarket
$CUBT
CUBT ticker
CUBT after hours

Curative Biotechnology Inc (CUBT:OTCMKTS) FAQs

toggle

What is the current price of Curative Biotechnology Inc (CUBT:OTCMKTS)?

The current price of Curative Biotechnology Inc (CUBT:OTCMKTS) is $0.0064.


toggle

Curative Biotechnology Inc (CUBT:OTCMKTS) absolute price change since previous trading day?

The absolute price change of Curative Biotechnology Inc (CUBT:OTCMKTS) since the previous trading day is $-0.00.


toggle

Curative Biotechnology Inc (CUBT:OTCMKTS) percentage price change since previous trading day?

The percentage price change of Curative Biotechnology Inc (CUBT:OTCMKTS) since the previous trading day is -13.51%.


toggle

What is This Week's average sentiment score for Curative Biotechnology Inc (CUBT:OTCMKTS)?

This Week's average sentiment score for Curative Biotechnology Inc (CUBT:OTCMKTS) is 71 out of 100.


toggle

What is This Week's average sentiment for Curative Biotechnology Inc (CUBT:OTCMKTS)?

This Week's sentiment for Curative Biotechnology Inc (CUBT:OTCMKTS) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.